NCT01398280View on ClinicalTrials.gov

Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Rosacea
Interventions
DRUG

Topical aminocaproic acid (ACA) mixed with Vanicream

25% Aminocaproic acid cream twice daily for up to 12 weeks.

DRUG

Vehicle cream

Vehicle cream moisturizer twice daily for up to 12 weeks

Trial Locations (1)

92037

University of California, San Diego Perlman Ambulatory Center, La Jolla

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT01398280 - Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation | Biotech Hunter | Biotech Hunter